Hydroxyindole-O-methyltransferase is another target for L-glutamate-evoked inhibition of melatonin synthesis in rat pinealocytes

Shougo Ishio, Hiroshi Yamada, Cheryl M. Craft, Yoshinori Moriyama

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Rat pinealocytes use L-glutamate as a modulator for melatonin synthesis. Upon binding of L-glutamate to the class II metabotropic glutamate receptor, norepinephrine (NE)-dependent formation of cAMP was inhibited, resulting in decreased serotonin-N-acetyltransferase (NAT) activity and melatonin output. Although L-glutamate at 1 mM caused 90% inhibition of melatonin synthesis, about 30% of the NAT activity remained, suggesting the presence of another target for L-glutamate. In this study, we found that L-glutamate also inhibits hydroxyindole-O-methyltransferase (HIOMT). The inhibition is reversible and dose-dependent: the maximal inhibition was obtained with more than 0.4 mM L-glutamate. Contrary to L-glutamate-evoked inhibition of NAT, agonists for class II metabotropic receptors such as (2S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG IV) had no effect on HIOMT. Neither (2S,3S,4S)-2-methyl-2-(carboxycyclopropyl)glycine (MCCG), an specific antagonist for class II mGluRs, nor dibutyryl cAMP restored the L-glutamate-evoked inhibition of HIOMT. Northern blot analyses revealed that L-glutamate significantly inhibits the expression of mRNA of NAT, but not that of HIOMT. These results indicated that HIOMT is an another target for L-glutamate due to its inhibition of melatonin synthesis, and the signaling pathway toward the inhibition is distinct from that of NAT. Copyright (C) 1999 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)73-78
Number of pages6
JournalBrain Research
Volume850
Issue number1-2
DOIs
Publication statusPublished - Dec 11 1999

Fingerprint

Acetylserotonin O-Methyltransferase
Melatonin
Glutamic Acid
Acetyltransferases
Arylalkylamine N-Acetyltransferase
Metabotropic Glutamate Receptors
Northern Blotting
Norepinephrine

Keywords

  • Hydroxyindole-O-methyltransferase
  • L-Glutamate
  • Melatonin
  • Pinealocyte
  • Serotonin-N-acetyltransferase

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Hydroxyindole-O-methyltransferase is another target for L-glutamate-evoked inhibition of melatonin synthesis in rat pinealocytes. / Ishio, Shougo; Yamada, Hiroshi; Craft, Cheryl M.; Moriyama, Yoshinori.

In: Brain Research, Vol. 850, No. 1-2, 11.12.1999, p. 73-78.

Research output: Contribution to journalArticle

@article{04100bb098844a2d91d36f27fa19892e,
title = "Hydroxyindole-O-methyltransferase is another target for L-glutamate-evoked inhibition of melatonin synthesis in rat pinealocytes",
abstract = "Rat pinealocytes use L-glutamate as a modulator for melatonin synthesis. Upon binding of L-glutamate to the class II metabotropic glutamate receptor, norepinephrine (NE)-dependent formation of cAMP was inhibited, resulting in decreased serotonin-N-acetyltransferase (NAT) activity and melatonin output. Although L-glutamate at 1 mM caused 90{\%} inhibition of melatonin synthesis, about 30{\%} of the NAT activity remained, suggesting the presence of another target for L-glutamate. In this study, we found that L-glutamate also inhibits hydroxyindole-O-methyltransferase (HIOMT). The inhibition is reversible and dose-dependent: the maximal inhibition was obtained with more than 0.4 mM L-glutamate. Contrary to L-glutamate-evoked inhibition of NAT, agonists for class II metabotropic receptors such as (2S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG IV) had no effect on HIOMT. Neither (2S,3S,4S)-2-methyl-2-(carboxycyclopropyl)glycine (MCCG), an specific antagonist for class II mGluRs, nor dibutyryl cAMP restored the L-glutamate-evoked inhibition of HIOMT. Northern blot analyses revealed that L-glutamate significantly inhibits the expression of mRNA of NAT, but not that of HIOMT. These results indicated that HIOMT is an another target for L-glutamate due to its inhibition of melatonin synthesis, and the signaling pathway toward the inhibition is distinct from that of NAT. Copyright (C) 1999 Elsevier Science B.V.",
keywords = "Hydroxyindole-O-methyltransferase, L-Glutamate, Melatonin, Pinealocyte, Serotonin-N-acetyltransferase",
author = "Shougo Ishio and Hiroshi Yamada and Craft, {Cheryl M.} and Yoshinori Moriyama",
year = "1999",
month = "12",
day = "11",
doi = "10.1016/S0006-8993(99)02102-2",
language = "English",
volume = "850",
pages = "73--78",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Hydroxyindole-O-methyltransferase is another target for L-glutamate-evoked inhibition of melatonin synthesis in rat pinealocytes

AU - Ishio, Shougo

AU - Yamada, Hiroshi

AU - Craft, Cheryl M.

AU - Moriyama, Yoshinori

PY - 1999/12/11

Y1 - 1999/12/11

N2 - Rat pinealocytes use L-glutamate as a modulator for melatonin synthesis. Upon binding of L-glutamate to the class II metabotropic glutamate receptor, norepinephrine (NE)-dependent formation of cAMP was inhibited, resulting in decreased serotonin-N-acetyltransferase (NAT) activity and melatonin output. Although L-glutamate at 1 mM caused 90% inhibition of melatonin synthesis, about 30% of the NAT activity remained, suggesting the presence of another target for L-glutamate. In this study, we found that L-glutamate also inhibits hydroxyindole-O-methyltransferase (HIOMT). The inhibition is reversible and dose-dependent: the maximal inhibition was obtained with more than 0.4 mM L-glutamate. Contrary to L-glutamate-evoked inhibition of NAT, agonists for class II metabotropic receptors such as (2S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG IV) had no effect on HIOMT. Neither (2S,3S,4S)-2-methyl-2-(carboxycyclopropyl)glycine (MCCG), an specific antagonist for class II mGluRs, nor dibutyryl cAMP restored the L-glutamate-evoked inhibition of HIOMT. Northern blot analyses revealed that L-glutamate significantly inhibits the expression of mRNA of NAT, but not that of HIOMT. These results indicated that HIOMT is an another target for L-glutamate due to its inhibition of melatonin synthesis, and the signaling pathway toward the inhibition is distinct from that of NAT. Copyright (C) 1999 Elsevier Science B.V.

AB - Rat pinealocytes use L-glutamate as a modulator for melatonin synthesis. Upon binding of L-glutamate to the class II metabotropic glutamate receptor, norepinephrine (NE)-dependent formation of cAMP was inhibited, resulting in decreased serotonin-N-acetyltransferase (NAT) activity and melatonin output. Although L-glutamate at 1 mM caused 90% inhibition of melatonin synthesis, about 30% of the NAT activity remained, suggesting the presence of another target for L-glutamate. In this study, we found that L-glutamate also inhibits hydroxyindole-O-methyltransferase (HIOMT). The inhibition is reversible and dose-dependent: the maximal inhibition was obtained with more than 0.4 mM L-glutamate. Contrary to L-glutamate-evoked inhibition of NAT, agonists for class II metabotropic receptors such as (2S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG IV) had no effect on HIOMT. Neither (2S,3S,4S)-2-methyl-2-(carboxycyclopropyl)glycine (MCCG), an specific antagonist for class II mGluRs, nor dibutyryl cAMP restored the L-glutamate-evoked inhibition of HIOMT. Northern blot analyses revealed that L-glutamate significantly inhibits the expression of mRNA of NAT, but not that of HIOMT. These results indicated that HIOMT is an another target for L-glutamate due to its inhibition of melatonin synthesis, and the signaling pathway toward the inhibition is distinct from that of NAT. Copyright (C) 1999 Elsevier Science B.V.

KW - Hydroxyindole-O-methyltransferase

KW - L-Glutamate

KW - Melatonin

KW - Pinealocyte

KW - Serotonin-N-acetyltransferase

UR - http://www.scopus.com/inward/record.url?scp=0032760198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032760198&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(99)02102-2

DO - 10.1016/S0006-8993(99)02102-2

M3 - Article

C2 - 10629750

AN - SCOPUS:0032760198

VL - 850

SP - 73

EP - 78

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -